TWiV 926: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses guidance for prevention and treatment of monkeypox, post-infectious symptoms among children and adolescents, profiling post-infectious syndromes of different variants, comparison of vaccine Ankara vs intradermal routes of administration, infection in vaccinated individuals treated with or without PAXLOVID, duration of symptoms with positive rapid antigen after infection, epidemiologic characteristics of monkeypox, and sequelae of post-acute infection.
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- Guidance\xa0for prevention & treatment of Monkeypox (CDC)
- Post-infection symptoms among\xa0children and adolescents\xa0(CDC)\xa0
- Profiling post-infection syndromes in\xa0different variants\xa0(medRxiv)
- Comparison\xa0\xa0of vaccinia Ankara (MVA) vs intradermal routes of administration (NIH)
- PAXLOVID patient eligibility\xa0screening checklist (FDA)
- Remdesivir fact sheet\xa0for providers (Veklury)\xa0
- Bebtelovimab fact sheet\xa0for providers (FDA)
- Infection in vaccinated individuals treated with or without\xa0PAXLOVID\xa0(medRxiv)
- Duration of symptoms\xa0with positive rapid antigen after infection\xa0(J Virological Methods)
- Epidemiologic characteristics\xa0of Monkeypox (CDC)
- Sequelae of\xa0post-acute infection\xa0(ScienceDirect)\xa0
- Contribute to\xa0Floating Doctors fundraiser at PWB
- Dr. Griffin\u2019s treatment guide (pdf)
- Letters read\xa0on TWiV 926
- Timestamps by Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv